Updated on Jun 30, 2022 | Inside
The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai has been named a National Cancer Institute (NCI)-designated Cancer Center, an honor reserved for an elite group of U.S. institutions committed to researching and treating cancer.
In conjunction with the NCI designation, The Tisch Cancer Institute received a five-year, $8.5 million grant to support research and the recruitment of top physicians and scientists. More than 50 of the nation’s leading cancer researchers have joined The Tisch Cancer Institute since it was established in 2008. (more…)
Updated on Jun 30, 2022 | Inside
Fifteen high school, college, and graduate students who aspire to careers in health care participated in recent internships throughout the Mount Sinai Health System. The initiative, which provides opportunities to students from groups underrepresented in health care, is supported by the Office for Diversity and Inclusion (ODI) in partnership with five local organizations: the Greater New York Hospital Association (GNYHA); All Stars Project, Inc.; Committee for Hispanic Children and Families; Prep for Prep; and YouthBridge-NY. (more…)
Updated on Jun 30, 2022 | Inside
Trailblazing neurogenetics researcher Alison M. Goate, DPhil, was presented with the Khalid Iqbal, PhD, Lifetime Achievement Award in Alzheimer’s Disease Research during the 2015 Alzheimer’s Association International Conference® held recently in Washington, D.C. The award honors individuals who have made significant, fundamental contributions to Alzheimer’s research, either through a single specific scientific discovery or a body of work. Dr. Goate, who has been studying the genetics of Alzheimer’s disease for more than 27 years, reported the first genetic mutation that causes an inherited form of Alzheimer’s and co-led a team of researchers that reported on some of the first disease-causing genetic mutations discovered for frontotemporal dementia. Her current research focuses on understanding the genetic risk factors for the more common, late-onset form of Alzheimer’s disease. Dr. Goate is Professor of Neuroscience, Genetics and Genomic Sciences, and Neurology for the Mount Sinai Health System and Director of the Ronald M. Loeb Center for Alzheimer’s Disease at the Icahn School of Medicine at Mount Sinai.
Updated on Jun 30, 2022 | Inside
Eight specialties within the Mount Sinai Health System were ranked among the top 25 in the nation, according to the 2015-2016 U.S. News & World Report Best Hospitals rankings, released in July. The specialties included seven at The Mount Sinai Hospital: Cardiology/Heart Surgery; Diabetes/Endocrinology; Ear, Nose & Throat (ENT); Gastroenterology/GI Surgery; Geriatrics; Nephrology; Neurology/Neurosurgery; and the Department of Ophthalmology at New York Eye and Ear Infirmary of Mount Sinai. Among the top 25, four specialties moved higher in the rankings between 2014 and 2015, led by Cardiology/Heart Surgery, which now stands at No. 7, up from No. 10; Gastroenterology/GI Surgery at No. 8, up from No. 9; Neurology/Neurosurgery at No. 14, up from No. 15; and Nephrology, which moved up to No. 23 from No. 47. (more…)
Updated on Jun 30, 2022 | Inside
A total of 241 physicians from the Mount Sinai Health System’s seven hospital campuses and an additional 34 physicians from Mount Sinai’s affiliated hospitals were represented in New York magazine’s recently released list of “Best Doctors in New York.” The 275 physicians represented 21 percent of the overall 1,282 area doctors on the 2015 list, available online and in the June 8-14, 2015, print edition. The list covers physicians from throughout the New York metropolitan region, including Connecticut and New Jersey. (more…)
Updated on Jun 30, 2022 | Inside, Research
A protein that promotes abnormal growth in melanoma cells has been identified for the first time by a team of researchers led by Emily Bernstein, PhD, Associate Professor of Oncological Sciences, and Dermatology, at the Icahn School of Medicine at Mount Sinai.
The novel discovery that the H2A.Z.2 protein is highly expressed in melanoma, appears to turn on the cell cycle, and makes melanoma cells grow faster, could also lead to therapeutic strategies that serve to inhibit cell proliferation. The results of Dr. Bernstein’s study were published in the July 2, 2015, issue of Molecular Cell. (more…)
